#BlueNovember
withRadiotheranostics
Emphasizing the value of radiotheranostics in detection and multidisciplinary care.
#BlueNovember
withRadiotheranostics
This November, we bring together Urology, Oncology, and Nuclear Medicine to advance prostate cancer care, highlighting the benefits of integrating radiotheranostics into the prostate cancer care pathway and practical ways to implement it.
First things, first: Early Detection
In collaboration with PRAISE-U

Screening
PRAISE-U is a consortium that works to encourage early detection and diagnosis of prostate cancer through customized and risk-based screening programs. Here you can access downloadable quick references detailing European health system backgrounds, local screening practices, the state of play, and recommendations.

When to use PET scan in early disease
Discover Ontario Institut for Cancer Research's educational videos for professionals on PSMA PET/CT imaging and its role in prostate cancer care, developed with leading radiation oncology and nuclear medicine experts to improve diagnosis, staging, and treatment planning.
Dr. Bauman is a Radiation Oncologist specializing in Genitourinary and Central Nervous System Malignancies. He is also the Professor and Chair/Chief of the Department of Oncology at the Schulich School of Medicine and Dentistry, University of Western Ontario in London, Ontario and is a Scientist, London Health Sciences Centre Research Institute. Dr. Bauman’s primary areas of clinical practice are in genitourinary and central nervous system tumors and areas of research interest are multi-modality image guided radiotherapy and cancer imaging.


Refer a patient
Radioligand Therapy can improve patients' quality of life. If you’re ready to refer a patient but don’t know where to start, our global map makes it easy: discover over 1,000 centers worldwide offering this life-changing treatment.
#BlueNovember
WithRadiotheranostics
During November, each week, we’ll share new content showcasing the benefits of integrating radiotheranostics into the prostate cancer care pathway — and practical ways to implement it. Stay tuned!
